Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

Endovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

Researchers continue to advance the science to determine best treatments for stroke. Based on an international study of 530 patients, researchers discovered that while the clot retrieval procedure ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

China: A recent study published in the Journal of Stroke and Cerebrovascular Diseases has highlighted the potential of ...

Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors by enhancing blood flow ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

LOS ANGELES -- For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive ...